CLINICAL ROLE -
Trends in Statin Treatment Costs and Potential Impact of Novel Therapies
Generic atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.
Impact of New Oral Therapies on Multiple Sclerosis Cost and Utilization Trends
Multiple sclerosis (MS) is of interest because it is one of the most costly neurological diseases and the introduction of the first oral treatments in 2010 amplified high treatment costs of MS even further.
2 Clarke Drive Cranbury, NJ 08512